Oxidative stress (OS) is the loss of balance between oxidants and antioxidants, caused by accumulation of reactive oxygen species (ROS) within the cell. Cumulative production of ROS causes a loss of balance between these molecules and the cellular antioxidant systems, promoting cellular damage (Kurtoglu, Ugur, Baltaci & Undar, 2003; Rossignol & Frye, 2012; Valko, Rhodes, Moncol, Izakovic & Mazur, 2006). OS and Redox balance can be regulated by dietary components, either with oxidant or antioxidant activity. These components comprise a variety of micronutrients, including iron (Evans & Halliwell, 2001). Damage caused by oxidative stress in cells includes alterations in protein functions due to polypeptide fragmentation, formation of protein-protein networks and modifications of amino acid side chains to form hydroxyl or carbonyl derivatives (Taskiran, Nesil & Alkan, 2007). Nucleic acid damage occurs mainly in mitochondrial deoxyribonucleic acid (mtDNA), as the inner mitochondrial membrane is the main production site of reactive oxygen singlets (O^-) (Kirkinezos & Moraes, 2001). In membrane lipids, OS generates an enormous variety of peroxidation products, including aldehydes, hydroxy-alkenals, acrolein, malondialdehyde (MDA), glyoxal, along with more stable products, such as ketones and alkanes, which exhibit a variety of biological properties (Esterbauer, 1993; Negre-Salvayre, Coatrieux, Ingueneau & Salvayre, 2008). Lipid Peroxidation end products can disturb normal cellular processes (Negre-Salvayre et al., 2008).

Iron is considered an essential micronutrient for cellular redox reactions. It is present in different forms in all tissues and interacts with oxygen, generating ROS through the Fenton and Haber-Weiss reactions, which can lead to oxidative stress (Batista-Nascimento, Pimentel, Menezes & Rodrigues-Pousada, 2012). Iron uptake within cells must be regulated to provide an adequate level for cellular functions and prevent its accumulation and possible toxic effects. Both excessive and decreased iron concentrations may lead to OS and cellular damage (Puntarulo, 2005). Oxidative damage due to altered iron homeostasis has been related to mitochondrial dysfunction, since mitochondria use approximately 90% of cellular oxygen, leading to production of a significant amount of superoxide and other RO (Walter et al., 2002). The consequences of iron-dependent OS have been studied in detail, particularly in conditions of iron overload. Various pathological characteristics of neurodegenerative diseases, cancer, atherosclerosis and ageing are attributed to iron-dependent production of ROS and induction of OS (Casanueva & Viteri, 2003). For example, DNA telomere shortening and cellular ageing have been related to increased polyunsaturated lipid oxidation dependent on significant iron overload, as measured by increased ferritin and thiobarbituric reactive species (TBARS) in plasma (Murillo-Ortiz et al., 2016).

Cells from the CNS, particularly neurons, are among the most sensitive to oxidative damage due to their high metabolic rate, limited capacity for regeneration and high iron content (Smith, Park, Krause & Banik, 2013). Furthermore, microglia and astrocytes promote OS mediated by ROS during neuroinflammatory processes (Ortiz et al., 2013). Iron appears to be widely distributed in the CNS and it has been associated with OS and induction of cell death, particularly in pathological conditions related to ageing and neurodegeneration (Farina, Avila, da Rocha & Aschner, 2013; Zorzi, Zibordi, Chiapparini & Nardocci, 2012). Neurodegenerative disorders associated with iron can be a result of both iron accumulation in specific brain regions or defects in iron metabolism and homeostasis (Batista-Nascimento et al., 2012).

Iron deficiency (ID) is a major cause of motor and cognitive dysfunction, particularly in developing organisms, as it decreases dendritic branching, neuronal interconnections and myelinization in different areas of the CNS (Pra, Franke, Henriques & Fenech, 2012). ID anemia is a health problem affecting around one billion people worldwide, according to the World Health Organization (WHO), with children, adolescents, and pregnant women being the most affected groups (WHO, 2001). Normal iron requirements are often not covered by diet, due to insufficient content and low bioavailability (Michaca et al., 2012). Despite its importance for CNS development and functions, the possible relationship between oxidative stress in the CNS and iron deficiency has not been determined. In this study, we sought to determine how chronic ID affects oxidative stress in the CNS, specifically regarding damage to lipids in nervous tissue.

All experiments were performed in the Neurochemistry Laboratory at the Faculty of Medicine, Universidad Autónoma del Estado de México. All animal experiments were carried out in accordance with local regulations. All experiments were approved by the Research Ethics Committee of the Faculty of Medicine, Universidad Autónoma del Estado de México.

It has been established that the nervous system is vulnerable to injury mediated by oxidative stress given its high metabolic activity, limited antioxidant capacity, increased production of ROS (Diniz, et al., 2015), high polyunsaturated fatty acid (PUFA) content (Shichiri, 2014), high iron content, particularly in the substantia nigra and dopaminergic neurons (Jellen et al., 2012), and its high surface to membrane ratio (Tewari, Mahendru, Sinha & Bilotta, 2014). ROS are highly reactive and can induce lipid peroxidation and accumulation of its products when generated near cell membranes, promoting cellular damage (Rahman & Adcock, 2006).

As noted previously, significant iron concentrations are widely distributed in the CNS (Zorzi et al., 2012). Since iron is known to participate in intracellular redox reactions and its concentration has been related to the induction of oxidative stress, our initial assumption was that iron deficiency might increase oxidative damage in the central nervous system, as has been observed in other organs such as liver, kidney and the intestinal mucosa (Knutson, Walter, Ames & Viteri, 2000; Walter et al., 2002), were oxidative damage to mitochondrial DNA and lipid membranes has been related to a decrease in the mitochondrial respiratory efficiency caused by iron deficiency (Kirkinezos & Moraes, 2001; Walter et al., 2002). However, the results contradict the initial assumption, since under conditions of iron deficiency in the CNS, a significant decrease in the formation of lipid peroxidation products is observed, compared to basal values in the control group, indicating as well that iron deficiency may impair the production of ROS in nervous tissue in the absence of antigenic stimulation.

Low levels of ROS have physiologically relevant functions as signaling molecules, and in innate and adaptive immune cells and are essential for pathways initiated by Toll-Like Receptors (TLRs), including TLR1, TLR2, and TLR4, and for optimal bactericidal activity of macrophages. Low ROS concentrations activate proliferative pathways, serving as signals to support stem-cell proliferation. By contrast, high levels of ROS impair stem-cell activate signaling pathways that limit self-renewal but do not necessarily cause cellular damage (Ray, Huang & Tsuji, 2012). Redox signaling is required for numerous cellular processes, as indicated by the role of ROS in proper cellular differentiation, tissue regeneration, and prevention of aging. It is also crucial in regulating signaling pathways that control various disease states, including tumor genesis, autoimmunity, and loss of tissue regeneration with age (Ray et al., 2012; Schieber & Chandel, 2014). Thus, decreased ROS production in the nervous tissue due to iron deficiency might be related to the observed decreases in dendritic branching, neuronal interconnections and myelinization that have been associated to motor and cognitive dysfunction in ferropenic iron deficiency anemia (Pra et al., 2012).

The spleen, like the CNS, has a high metabolic rate, due to leukocyte activity and its iron recycling functions, making it susceptible to oxidative stress damage (Javed et al., 2010). While the CNS contains microglia as immune effector cells (Kreutzberg, 1996), macrophages in the spleen respond to a variety of activation stimuli with the production of high concentrations of ROS (Cathcart, 2004; Hume et al., 2002).

In the spleen the red pulp is anatomically well suited for its blood-filtering function, by the combination of an open and sinusoidal venous system, and also contains macrophages that have special properties for fighting bacteria and facilitating iron metabolism. An important task of splenic macrophages is iron recycling, regulated by the requirements of the bone marrow (Knutson & Wessling-Resnick, 2003). Macrophages in the spleen express NRAMP1 (natural-resistance-associated macrophage protein 1), a transporter for divalent metals across the phagosomal membrane, useful for shuttling iron outside the phagosomes, reducing iron availability for ingested microorganisms and limiting their growth (Mebius & Kraal, 2005). Although the spleen has an elevated amount of immune effector cells, including macrophages that are involved in the production of large quantities of ROS upon activation, our results show that oxidative damage in the spleen appears to be lower than in the CNS, which contains a lower number of macrophage-like cells (microglia).

Nonetheless, in contrast to the effect of iron deficiency in CNS, we observed a significant increase in MDA production in the ID group, compared to the controls. These data could suggest an impaired function of spleen cells derived from an increased requirement for iron recycling from a limited stores source, leading to possible tissue damage or impaired stem-cell generation in this tissue, due to oxidative stress by enhanced ROS production in splenocytes, activating signaling pathways that limit self-renewal (Mittler et al., 2011).

In conclusion, this results show altered profiles of the lipid peroxidation end product MDA in the CNS and spleen of ID mice. Reduced oxidative damage in the CNS might be related to a decreased production of ROS in nervous tissue, a possibility that should be addressed in future studies, since even in the absence of lipid damage in the tissue, decreased production of these molecules may be related to known alterations in neuronal signaling and functions that become manifest in the long term as cognitive and motor deficits observed in anemic individuals. Increased MDA production in the spleen may be relevant for diminished leukocyte functions and an impaired immune response under iron-deficient conditions, promoting enhanced susceptibility to infections. Our identification of changes in lipid peroxidation products under ID identifies additional adverse effects of this pathology on the organism and emphasizes the need for adequate prevention and correcting measures for it, given the high incidence and prevalence of iron deficiency worldwide.